Reader Training Renal

Following guidance from experienced PET/CT readers, this reader training program is designed to optimize PET/CT reading skills for
89Zr-girentuximab and increase confidence in identifying renal pathology. These learning modules include, anatomy review, tracer and technical considerations, video case studies with teaching points and interactive Test Your Knowledge opportunities.

Reader Training - Modules 1, 2 and 3
Module 1
Introduction  | 89Zr-girentuximab Reader Training
Presented by: Jeremie Calais, MD, PhD
Module 2
Renal PET/CT  | 89Zr-girentuximab Reader Training
Presented by: Viraj Master, MD, PhD, FACS • Brian M. Shuch, MD
Module 3 - Parts One, Two & Three:
Advanced Reading Skills  | 89Zr-girentuximab Reader Training
Presented by:
Jeremie Calais, MD, PhD • James Nagarajah, MD • Sze Ting Lee, MD, PhD
Reader Training Prostate

Reader Training is an educational resource from Telix Pharmaceuticals, makers of Illuccix® (kit for the preparation of gallium Ga 68 gozetotide Injection), designed to improve PSMA-11 PET/CT reader skills and increase confidence in identifying pathology while following guidelines to optimize PET/CT reading. Learning modules will include, learning objectives, case study reviews and teaching points presented with video, slides, supporting resources and clinical articles.

Reader Training - Modules 1, 2 and 3
Module 1 - Parts One & Two:
The Basics of 68Ga PSMA-11 PET/CT
Presented by: Nat Lenzo, MD
Module 2
Considerations for 68Ga-PSMA-11 PET/CT Imaging Interpretation
Presented by: Jaideep S. Sohi, MD
Module 3 - Parts One, Two & Three:
Advanced Reading Skills: A Comprehensive PSMA-11 PET/CT Case Study Review
Presented by: Stefano Fanti, MD and Andrea Farolfi, MD
Other Educational Resources

The content in this section links to third-party websites. Therefore, to view these educational resources, you will be be leaving TelixU and redirected to another website

Disclaimer: Telix is proud to sponsor this educational article by Applied Radiology®, however, Telix did not participate in the creation of this educational content and is not responsible for any content on or the privacy practices of third-party sites.

Applied Radiology
Not All Prostate-Specific Membrane Antigen Imaging Agents Are Created Equal: Diagnostic Accuracy of Ga-68 PSMA-11 PET/CT for Initial and Recurrent Prostate Cancer

Disclaimer: Telix is proud to sponsor this educational series with Urology Times®, however, Telix did not participate in the creation of this educational content and is not responsible for any content on or the privacy practices of third-party sites.

Urology Times
Clinical Updates on PSMA-PET Imaging for Prostate Cancer

Key opinion leaders discuss the latest PSMA-PET imaging updates for prostate cancer and consider how real-world practice has evolved.